Home › Funds › ANTIPODES PARTNERS Ltd › B

ANTIPODES PARTNERS Ltd position in B

BARRICK MNG CORP · Materials

ANTIPODES PARTNERS Ltd reported holding 3,280,102 shares of B (BARRICK MNG CORP) in its Q3 2026 13F filing — a position valued at US$133.4M, representing 2.46% of its reported portfolio and ranking #12 among its reported holdings. ANTIPODES PARTNERS Ltd has disclosed B holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)3.28M sh
Reported value held$133.41M
Portfolio Weight2.46%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ANTIPODES PARTNERS Ltd's B position evolved

ANTIPODES PARTNERS Ltd first disclosed a stake in B in Q2 2025 at 8,131,094 shares (US$169.3M). The position peaked in Q4 2025 at 4,475,725 shares, worth US$194.9M. Across 6 filings, ANTIPODES PARTNERS Ltd increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,280,102 shares valued at US$133.4M — a reduction of -557,875 shares quarter over quarter.. Notable position changes include a 31% trim in Q3 2025 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 8.13M $169.30M New
Q3 2025 5.63M $184.42M Reduce
Q4 2025 4.48M $194.94M Reduce
Q1 2026 4.06M $165.42M Reduce
Q2 2026 3.84M $140.97M Reduce
Q3 2026 3.28M $133.41M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About B and 13F data

B (BARRICK MNG CORP) is a Materials company. 62 other funds we track also report a position in B — the largest reported positions include Capital International Investors (US$2.71B), VAN ECK ASSOCIATES CORP (US$2.60B), Arrowstreet Capital (US$1.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding B

All B fund holders →

FAQ

How long has ANTIPODES PARTNERS Ltd held B?

ANTIPODES PARTNERS Ltd has disclosed B holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is ANTIPODES PARTNERS Ltd's current position in B?

As of Q3 2026, ANTIPODES PARTNERS Ltd holds 3.28M shares of B (BARRICK MNG CORP), valued at $133.41M, representing 2.46% of its reported portfolio and ranking #12.

Has ANTIPODES PARTNERS Ltd been buying or selling B?

In the latest 13F filing (Q3 2026), ANTIPODES PARTNERS Ltd reduced its position in B. The position peaked in Q4 2025 at 4.48M shares.

Which other funds hold B?

Other major institutional holders of B include Capital International Investors, VAN ECK ASSOCIATES CORP, Arrowstreet Capital, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.